Download PDF
1 / Pages

Other users also viewed these articles

Coping With Low Mortality and Exacerbation Rate Differences Between COPD Triple Therapy Studies, and a Proposal for Upcoming Studies Alberto Ruano-Raviña; Alberto Fernández-Villar; José Luis López-Campos;
Arch Bronconeumol. 2020;56:336-8
Implicaciones clínicas del uso de la triple terapia en combinación de dosis fija en EPOC: del ensayo al paciente José Luis López-Campos; Laura Carrasco-Hernández; Lucas Román Rodríguez; Esther Quintana-Gallego; Carmen Carmona Bernal; Bernardino Alcázar Navarrete;
Arch Bronconeumol. 2020;56:242-8
Inhaled Maintenance Therapy in the Follow-Up of COPD in Outpatient Respiratory Clinics. Factors Related to Inhaled Corticosteroid Use. EPOCONSUL 2021 Audit Myriam Calle Rubio; Marc Miravitlles; José Luis López-Campos; Bernardino Alcázar Navarrete; Juan José Soler Cataluña; Manuel E. Fuentes Ferrer; Juan Luis Rodríguez Hermosa;
Arch Bronconeumol. 2023;59:725-35